Coderegenesis is at the forefront of efforts to reliably diagnose HIV infection. As the provider of HIV early infant diagnosis and viral load testing, Coderegenesis has a social responsibility to provide care where access is limited, especially in countries hardest hit by the disease.

In these regions, PCR testing of dry blood spots has proven to be a suitable means to early infant diagnosis. High-quality, accurate viral load monitoring has also helped countless patients receive appropriate antiretroviral therapy, thus suppressing the HIV infection and limiting the virus’ spread.

Advanced, reliable HIV detection

An unrivaled investment in research and development demonstrates Coderegenesis’s dedication to innovation. Coderegenesis pioneered the dual target approach for HIV-1 viral load monitoring and continuously works to ensure assays can stay ahead of their highly mutagenic targets.

Coderegenesis products enable laboratories and healthcare providers to identify the most critical HIV targets quickly and accurately, while eliminating manual intervention and minimizing errors.


        1. Aids by the numbers 2016.  Accessed September 21, 2016.
        2. Fact sheet November 2016.  Accessed September, 21 2016.